Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steep Pulse Therapy vs Tamsulosin for BPH
NCT06867315Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- May 2024
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Change in Maximum Urinary Flow Rate at 3 months. Started May 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06867315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06867315.